Deerfield Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,504,578
Closed -$36.6M – 115
2023
Q1
$36.6M Sell
1,504,578
-1,920,274
-56% -$42M 0.82% 36
2022
Q4
$73.3M Sell
3,424,852
-819,246
-19% -$17.5M 1.52% 23
2022
Q3
$76.1M Sell
4,244,098
-969,902
-19% -$12.7M 1.52% 21
2022
Q2
$50.2M Buy
5,214,000
+322,004
+7% +$4.04M 1.03% 33
2022
Q1
$82.3M Buy
4,891,996
+130,858
+3% +$1.93M 1.84% 16
2021
Q4
$79.6M Sell
4,761,138
-102,587
-2% -$1.68M 1.67% 16
2021
Q3
$79M Sell
4,863,725
-903,684
-16% -$9.8M 1.54% 18
2021
Q2
$36.4M Hold
5,767,409
– – 0.65% 52
2021
Q1
$35.6M Hold
5,767,409
– – 0.75% 46
2020
Q4
$39.9M Hold
5,767,409
– – 0.79% 41
2020
Q3
$32.5M Hold
5,767,409
– – 0.79% 38
2020
Q2
$29.4M Buy
5,767,409
+3,500,000
+154% +$14.6M 0.86% 38
2020
Q1
$7.8M Buy
2,267,409
+1,267,409
+127% +$7.41M 0.25% 77
2019
Q4
$8.58M Buy
+1,000,000
New +$3.57M 0.27% 62
2015
Q4
– Sell
-10,000
Closed -$405K – 131
2015
Q3
$405K Buy
+10,000
New +$530K 0.02% 131

Other funds holding ISEE

Deerfield Management's ISEE Position: Q2 2023 in Review

Deerfield Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 1,504,578 shares — an estimated $36.6M sold.

Deerfield Management first reported a position in ISEE in Q3 2015 and held it in 15 quarters. The position peaked at $82.3M in Q1 2022. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Deerfield Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Deerfield Management sold 1,504,578 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $36.6M.
  • Deerfield Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2015 and held it in 15 quarters.
  • Deerfield Management's IVERIC bio, Inc. Common Stock position peaked at $82.3M in Q1 2022.
  • 255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Deerfield Management's 13F filing for Q2 2023, filed 14 Aug 2023.